SCHEMBL6172274

SCHEMBL6172274

CC(c1ccnc(NC(=O)c2ccccc2)c1)C1(C(C)c2ccnc(NC(=O)c3ccccc3)c2)NC(=O)N(c2ccc(OC(F)(F)F)cc2)C1=O

nearest known ligand 0.40

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 1/20 0.40
GAA P10253 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
ALDH1A1 P00352 1/20 0.40
NTRK1 P04629 1/20 0.39
MAPK1 P28482 2/20 0.39
MAPKAPK2 P49137 1/20 0.39
PDE2A O00408 3/20 0.39
NPC1 O15118 2/20 0.38
RAB9A P51151 2/20 0.38
MAPK9 P45984 1/20 0.38
MAPK10 P53779 1/20 0.38
MTOR P42345 1/20 0.38
ABL1 P00519 2/20 0.38
SCN10A Q9Y5Y9 1/20 0.38
CBLB Q13191 1/20 0.38
ATM Q13315 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6175553 0.93 NPC1 (0.40) CYP3A4GAACYP2C9CYP2C19NTRK1
SCHEMBL6171136 0.93 CYP3A4 (0.47) CYP3A4GAACYP2C9CYP2C19ALDH1A1
SCHEMBL6173257 0.91 GRM5 (0.45) ALDH1A1NTRK1MAPKAPK2ABL1SCN10A
SCHEMBL6176861 0.89 PDE2A (0.39) CYP3A4GAACYP2C9CYP2C19MAPK1
SCHEMBL6173825 0.89 MAPK1 (0.42) MAPK1NPC1RAB9A
SCHEMBL6176554 0.89 BRAF (0.42) CYP3A4GAACYP2C9CYP2C19ALDH1A1
SCHEMBL6172794 0.88 MAPK1 (0.42) MAPK1
SCHEMBL6174597 0.87 MAPK1 (0.38) CYP3A4GAACYP2C9CYP2C19ALDH1A1
SCHEMBL6173261 0.86 IGF1R (0.41) MAPKAPK2ABL1
SCHEMBL6175145 0.86 ALDH1A1 (0.40) CYP3A4GAACYP2C9CYP2C19ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1599464-A2 NOVEL CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS Aventis Pharma S.A. (FR) 2005-11-30 EP disclosed
WO-2004070050-A2 CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS AVENTIS PHARMA S.A. (FR) 2004-08-19 WO disclosed